About Chiron
Preventing tranfusion-transmitted infection is what Chiron is all about. As the world leader in blood safety for the transfusion industry, we develop novel tools, products and services to protect the global blood supply.
Chiron is the blood screening business of Novartis Vaccines and Diagnostics, a division of Novartis AG that was created in 2006 following the acquisition of Novartis Vaccines and Diagnostics.
Corporate Information »
News
The Success Story of Israel
Along with a reputation for providing cutting-edge technology in multiple markets, notably the telecommunications and medical devices industries, Israel can now also boast of its decision to adopt the safest method of blood screening available.
President's Note
Gene Walther, President of Chiron and Global Head of Diagnostics, welcomes you to chiron.com.
Read On »
Events
Chiron maintains a calendar of events relevant to the transfusion community. Check back frequently for updates.
Press Releases
Look up current and archived Chiron-specific press releases here. For Novartis media releases, visit novartis.com